Rheumatoid Arthritis

FDA rejects potential blockbuster, requesting further safety data.

Companies race to join tofacitinib on the rheumatoid arthritis treatment market.

Alone or combined with methotrexate, benefits continued through week 104.

16.8% of RA patients in the study presented with major depression.

Research from UNC may bring medicine closer to understanding the conundrum.

Highly anticipated potential first-line treatment now a go in the United States.

Rheumatoid arthritis drug gets approved by European Commission.

European officials approved new biosimilar for select inflammatory diseases.

NIAID Director Anthony Fauci, MD is globally renowned for immunology research.

The association between periodontal disease, RA is a chicken-or-egg question.

New recommendations reprioritize some common RA drugs.

VA study found overall adherence low, but better in MTX and TNFi group.

RA most often impacts females. For men, it can threaten emasculation.

Schizophrenia and rheumatoid arthritis appear to have a DNA level connection.

Rheumatoid arthritis drugs treat inflammation, but not the underlying autoimmunity.

Treg and Breg cells can be very telling for rheumatoid arthritis treatment.

Arthro-haptic 3D printed prototypes give patients an emotional experience.

Patients who didn't respond to methotrexate may do well on baricitinib.

Eli Lily's rheumatoid arthritis drug baricitinib got Europe's okay.

Advanced techniques allowed researchers to isolate T-cells involved in RA.

Canadian authorities today approved Sanofi/Regeneron collaboration sarilumab.

A foot or ankle injury misdiagnosis can lead to chronic pain or arthritis.

Analysis finds that those with RA have same mortality rate as those without.

A new study leads back to the age-old question of incidence vs. diagnostics.

It's well known that arthritis doesn't mix well with other conditions. But where does healthcare go with that information?

The only consensus seems to be that walking is good for arthritis.

It might be time to retire the belief that bad weather is hurting joint pain even more.

A biosimilar to the world's biggest-selling drug performed well alongside it, according to top-line results announced recently.

Dutch researchers used radiolabeling to observe certolizumab in the body for the first time. Such studies could provide a greater understanding of how TNF inhibitors can be best used in the treatment of inflammatory conditions like arthritis.

Electric shocks, hot tea, and cryogenic freeze are just a few of the topics that came up in 2016 during the constant search to better understand and treat rheumatoid arthritis.